Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 223
  • Print this page
  • Email this page
This article has been cited by
1Determinants of COVID-19 Vaccine Acceptance in West Papua, Indonesia
Butet Agustarika,Simon L. Momot,Alva Cherry Mustamu
Open Access Macedonian Journal of Medical Sciences.2022;10(E)274
[DOI]
2Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
José María Díez,Carolina Romero,Júlia Vergara-Alert,Melissa Belló-Perez,Jordi Rodon,José Manuel Honrubia,Joaquim Segalés,Isabel Sola,Luis Enjuanes,Rodrigo Gajardo
Immunotherapy.2020;12(17)1247
[DOI]
3Challenges faced in establishing a dedicated 250 bed COVID-19 intensive care unit in a temporary structure
Shalendra Singh,George Cherian Ambooken,Rangraj Setlur,Shamik Kr Paul,Madhuri Kanitkar,Surinder Singh Bhatia,Ratnesh Singh Kanwar
Trends in Anaesthesia and Critical Care.2021;36(17)9
[DOI]
4SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development
Chiranjib Chakraborty,Manojit Bhattacharya,Bidyut Mallick,Ashish Ranjan Sharma,Sang-Soo Lee,Govindasamy Agoramoorthy
Expert Review of Clinical Pharmacology.2021;14(2)225
[DOI]
5Understanding COVID-19: From Origin to Potential Therapeutics
Muhammad Moazzam,Muhammad Imran Sajid,Hamza Shahid,Jahanzaib Butt,Irfan Bashir,Muhammad Jamshaid,Amir Nasrolahi Shirazi,Rakesh Kumar Tiwari
International Journal of Environmental Research and Public Health.2020;17(16)5904
[DOI]
6TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
Mohammad Azam Ansari,Qazi Mohammad Sajid Jamal,Suriya Rehman,Ahmad Almatroudi,Mohammad A. Alzohairy,Mohammad N. Alomary,Takshashila Tripathi,Ali H. Alharbi,Syed Farooq Adil,Mujeeb Khan,M. Shaheer Malik
Arabian Journal of Chemistry.2020;13(11)8069
[DOI]
7Acceptability of the COVID-19 Vaccine among Adults in Saudi Arabia: A Cross-Sectional Study of the General Population in the Southern Region of Saudi Arabia
Yahya S. Alqahtani
Vaccines.2021;10(1)41
[DOI]
8Response to: Status of Remdesivir: Not Yet Beyond Question!
Abinit Saha,Ashish Ranjan Sharma,Manojit Bhattacharya,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Archives of Medical Research.2021;52(1)104
[DOI]
9Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis
Masoumeh Adhami,Balal Sadeghi,Ali Rezapour,Ali Akbar Haghdoost,Habib MotieGhader
BMC Biotechnology.2021;21(1)104
[DOI]
10Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines
José Adão Carvalho Nascimento Júnior,Anamaria Mendonça Santos,Rafael Ciro Marques Cavalcante,Lucindo José Quintans-Júnior,Cristiani Isabel Banderó Walker,Lysandro Pinto Borges,Luiza Abrahão Frank,Mairim Russo Serafini
Drug Development and Industrial Pharmacy.2021;47(4)673
[DOI]
11In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury,Suprabhat Mukherjee
Journal of Medical Virology.2020;92(10)2105
[DOI]
12“Intensity, anxiety … but also, hope?” Reflections on care, whiteness, and emotions by women of color during the virocene
Angie Mejia,Danniella Balangoy,Chandi Katoch
Gender, Work & Organization.2022;29(4)1386
[DOI]
13The re-emerging human monkeypox virus: An urgent global health alert
Prithiviraj Nagarajan,Leena Rajathy Port Louis,Anusheela Howlader,Kumar Rangarajalu
Health Science Reports.2022;5(6)1386
[DOI]
14Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
Ratnadeep Saha,Pratik Ghosh,V. L. S. Prasad Burra
3 Biotech.2021;11(2)1386
[DOI]
15SARS CoV-2 infections in animals, two years into the pandemic
Sara Frazzini,Massimo Amadori,Lauretta Turin,Federica Riva
Archives of Virology.2022;11(2)1386
[DOI]
16Reported quality of life in countries with cases of COVID19: a systematic review
Maria Eduarda Melo-Oliveira,Danúbia Sá-Caputo,José Alexandre Bachur,Laisa Liane Paineiras-Domingos,Anelise Sonza,Ana Cristina Lacerda,Vanessa Mendonça,Adérito Seixas,Redha Taiar,Mario Bernardo-Filho
Expert Review of Respiratory Medicine.2021;15(2)213
[DOI]
17Reported quality of life in countries with cases of COVID19: a systematic review
Rinki Kumari,Anita Venaik,Jasmeet Singh,Rajesh K. Kesharwani
Expert Review of Respiratory Medicine.2022;15(2)349
[DOI]
18Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis
Roberto Ariel Abeldaño Zuñiga,Silvia Mercedes Coca,Giuliana Florencia Abeldaño,Ruth Ana María González-Villoria
Therapeutic Advances in Respiratory Disease.2021;15(2)175346662110072
[DOI]
19EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes
Cristina S. Ferreira,Yasmmin C. Martins,Rangel Celso Souza,Ana Tereza R. Vasconcelos
PeerJ.2021;9(2)e12548
[DOI]
20Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach
Samira Sanami,Milad Zandi,Behzad Pourhossein,Gholam-Reza Mobini,Mohsen Safaei,Atena Abed,Pooria Mohammadi Arvejeh,Fatemeh Amini Chermahini,Morteza Alizadeh
International Journal of Biological Macromolecules.2020;164(2)871
[DOI]
21Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India
Dibya Sundar Panda,Ranjan Kumar Giri,Anil Kumar Nagarajappa,Sakeenabi Basha
Human Vaccines & Immunotherapeutics.2021;17(10)3333
[DOI]
22Readiness and Attitude of Parents towards COVID -19 Vaccine Acceptance for their Children: A Study with Reference to Mumbra Region
Sakeenabi Dr. Aarti Vyas Varma
International Journal of Advanced Research in Science, Communication and Technology.2021;17(10)453
[DOI]
23Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
Xianfang Tang,Lijun Cai,Yajie Meng,JunLin Xu,Changcheng Lu,Jialiang Yang
Frontiers in Immunology.2021;11(10)453
[DOI]
24Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Hong-Zhi Chen,Ling-Li Tang,Xin-Ling Yu,Jie Zhou,Yun-Feng Chang,Xiang Wu
Infectious Diseases of Poverty.2020;9(1)453
[DOI]
25Simulink Modelling For Simulating Intensive Care Mechanical Ventilators
Paolo Tamburrano,Pietro De Palma,Andrew R. Plummer,Elia Distaso,Riccardo Amirante
E3S Web of Conferences.2020;197(1)07007
[DOI]
26

Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey

Mohammed Al-Mohaithef,Bijaya Kumar Padhi
Journal of Multidisciplinary Healthcare.2020;Volume 13(1)1657
[DOI]
27Diagnosis for COVID-19: current status and future prospects
MD Alamgir Kabir,Rajib Ahmed,Sheikh Muhammad Asher Iqbal,Rasheduzzaman Chowdhury,Ramasamy Paulmurugan,Utkan Demirci,Waseem Asghar
Expert Review of Molecular Diagnostics.2021;21(3)269
[DOI]
28Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review
Nidhi Chauhan,Shringika Soni,Abhinandan Gupta,Mohammad Aslam,Utkarsh Jain
Journal of Medical Virology.2021;93(4)1967
[DOI]
29Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
Lei-Yun Wang,Jia-Jia Cui,Qian-Ying OuYang,Yan Zhan,Yi-Min Wang,Xiang-Yang Xu,Lu-Lu Yu,Hui Yin,Yang Wang,Chen-Hui Luo,Cheng-Xian Guo,Ji-Ye Yin
EPMA Journal.2021;12(3)307
[DOI]
30Human menstrual blood-derived stem cells as immunoregulatory therapy in COVID-19: A case report and review of the literature
Juan Lu,Zhong-Yang Xie,Dan-Hua Zhu,Lan-Juan Li
World Journal of Clinical Cases.2021;9(7)1705
[DOI]
31Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
Kavya Srinivasan,Ashutosh Kumar Pandey,Ashlena Livingston,Sundararajan Venkatesh
Molecular Biomedicine.2021;2(1)1705
[DOI]
32SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
Chiranjib Chakraborty,Ashish Ranjan Sharma,Manojit Bhattacharya,Rudra P. Saha,Sanmitra Ghosh,Soham Biswas,Saikat Samanta,Garima Sharma,Govindasamy Agoramoorthy,Sang-Soo Lee
Infection, Genetics and Evolution.2021;89(1)104729
[DOI]
33Covid-19: a comprehensive review of a formidable foe and the road ahead
Arafat Hussain,Suniti Yadav,Vijay Hadda,Tejas M Suri,Pawan Tiwari,Saurabh Mittal,Karan Madan,Anant Mohan
Expert Review of Respiratory Medicine.2020;14(9)869
[DOI]
34Repurposing of the Herbals as Immune-Boosters in the Prevention and Management of COVID-19: A Review
Rinki Kumari,Anita Venaik,Md Al Hasibuzzaman,Simon Agongo Azure,Rudra P. Ojha,Ajay Kumar Sahi
Journal of Pure and Applied Microbiology.2021;15(1)1
[DOI]
35Acute Respiratory Distress Syndrome due to COVID-19 in India and efficacy of Indian Siddha drugs - A Trial of Lopinavir-Ritonavir
P. Rajeshbabu,K. Priadharsini,S.U. Mohammed Riyaz,Manikandan Dhayalan
Journal of Pure and Applied Microbiology.2022;16(2)763
[DOI]
36SARS-CoV-2: the prospects of the virus spreading and the course of the pathogenesis of coronavirus infection in various species of animals
M. S. Fedotova,A. Yu. Filippova,M. A. Omarov,K. S. Yurchenko,M. A. Gulyaeva
South of Russia: ecology, development.2022;17(1)6
[DOI]
37Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus
Chiranjib Chakraborty,Manojit Bhattacharya,Shyam Sundar Nandi,Ranjan K. Mohapatra,Kuldeep Dhama,Govindasamy Agoramoorthy
Veterinary Quarterly.2022;42(1)119
[DOI]
38Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection
Soumya Ranjan Mahapatra,Susrita Sahoo,Budheswar Dehury,Vishakha Raina,Shubhransu Patro,Namrata Misra,Mrutyunjay Suar
Expert Review of Vaccines.2020;19(9)871
[DOI]
39Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches
Federica Mannino,Alessandra Bitto,Natasha Irrera
Frontiers in Pharmacology.2020;11(9)871
[DOI]
40Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets
Syed Nisar Hussain Bukhari,Amit Jain,Ehtishamul Haq,Abolfazl Mehbodniya,Julian Webber
Diagnostics.2021;11(11)1990
[DOI]
41Factors Related to the Possibility of Accepting COVID-19 Vaccines: A Population-Based Cross-Sectional Study
Mahdieh Sheikh,Mina Sheikh,Noosha Samieefar,Saeid Safari
Interventional Pain Medicine and Neuromodulation.2022;2(1)1990
[DOI]
42Are vanadium complexes druggable against the main protease Mpro of SARS-CoV-2? – A computational approach
Thomas Scior,Hassan H. Abdallah,Siti Fatimah Zaharah Mustafa,José Antonio Guevara-García,Dieter Rehder
Inorganica Chimica Acta.2021;519(1)120287
[DOI]
43Ten challenging questions about SARS-CoV-2 and COVID-19
Majid Teymoori-Rad,Saeed Samadizadeh,Alijan Tabarraei,Abdolvahab Moradi,Mahsa Bataghva Shahbaz,Alireza Tahamtan
Expert Review of Respiratory Medicine.2020;14(9)881
[DOI]
44A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics
Jyoti Verma,Naidu Subbarao
Archives of Virology.2021;14(9)881
[DOI]
45Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
Seyed Mehdi Sadat,Mohammad Reza Aghadadeghi,Masoume Yousefi,Arezoo Khodaei,Mona Sadat Larijani,Golnaz Bahramali
Molecular Biotechnology.2021;63(5)389
[DOI]
46Emergence of monkeypox: Another concern amidst COVID-19 crisis
Balamurugan Shanmugaraj,Narach Khorattanakulchai,Waranyoo Phoolcharoen
Asian Pacific Journal of Tropical Medicine.2022;15(5)193
[DOI]
47Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex
Manojit Bhattacharya,Ashish Ranjan Sharma,Bidyut Mallick,Garima Sharma,Sang-Soo Lee,Chiranjib Chakraborty
Infection, Genetics and Evolution.2020;85(5)104587
[DOI]
48Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
Anuja Pandit,Nirav Bhalani,B.L. Shashi Bhushan,Parshottam Koradia,Shweta Gargiya,Vinay Bhomia,Kevinkumar Kansagra
International Journal of Infectious Diseases.2021;105(5)516
[DOI]
49How a catastrophic situation turns into an exceptional opportunity: Covid-19 pandemic in Iran and challenges of online education for new English language educators
Parisa Badrkhani
Interactive Learning Environments.2021;105(5)1
[DOI]
50Reasons for hesitancy to take COVID-19 vaccine: A survey amongst healthcare workers
GSwetha Rao,R Ram,B Vengamma
Journal of Clinical and Scientific Research.2022;11(1)17
[DOI]
51A survey on COVID-19 vaccine acceptance and concern among Malaysians
S. A. R. Syed Alwi,E. Rafidah,A. Zurraini,O. Juslina,I. B. Brohi,S. Lukas
BMC Public Health.2021;21(1)17
[DOI]
52Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework
Neeraj Kumar,Damini Sood,Ramesh Chandra
RSC Advances.2020;10(59)35856
[DOI]